R&D
Limitations of current industrialization of organoids

① Lack of large-scale production platform

② Having tedious differentiation steps and a lengthy process

③ High production cost

④ Deviation in cell types

⑤ Limited functionality and structural features

⑥ There are significant differences between individuals and batches

Introduction to MICRO Technology

NUOXINTE's MICRO technology can produce a large number of mature organoids with the same shape and size in a short period of time, greatly reducing production costs. If you need large-scale organoids with small individual differences, NUOXINTE's MICRO organoid technology can provide a solution.

MICRO Brain®

① Large scale production of 96 and 384 well plates

② Small differences between individuals and batches

③ Shortened production cycle and low cost

④ Rich mature dopamine neurons

⑤ Production of Neurorelaxin like Particles

⑥ Mature electrophysiological activity

MICRO Liver®

① Large scale production of 96 well plates

② Low production cost

③ Diverse cell types (liver cells, bile duct cells, hepatic stellate cells, Kupffer cells, sinusoidal endothelial cells)

④ Complete functional and structural features

⑤ Simulation of non-alcoholic fatty liver disease (NAFLD)

Multiple types of organs and applications

① Brain organoids used for ASD, AD, PD, and neurotoxicity

② Liver organoids used for NAFLD/NASH hepatotoxicity

③ Heart like organs used for cardiac toxicity

④ Intestinal organoids used for microorganisms and functional foods

⑤ Skin organoids are used for hair, whitening, and UV protection

⑥ Respiratory organs used for infectious diseases

⑦ Cancer organoids used for chemotherapy drugs

⑧ Lung organoids are used for fibrosis and pulmonary toxicity